Skip to main navigation
Skip to search
Skip to main content
Sort by
Medicine and Dentistry
All Cause Mortality
47%
Anthracycline
42%
Biological Marker
30%
Breast Cancer
54%
C Reactive Protein
15%
Cancer Therapy
31%
Cardio-Oncology
57%
Cardiopulmonary Exercise Test
21%
Cardiotoxicity
42%
Cardiovascular Disease
18%
Congestive Heart Failure
100%
Coronary Angiography
16%
Coronary Artery Disease
20%
COVID-19
77%
Diastolic Dysfunction
36%
Diastolic Function
35%
Disease Course
19%
Diseases
15%
Early Diagnosis
15%
Echocardiography
84%
Ejection Fraction
77%
Hazard Ratio
19%
Heart Injury
16%
Heart Left Ventricle Ejection Fraction
48%
Heart Left Ventricle Function
19%
Hemodynamic
36%
Immune Checkpoint Inhibitor
90%
Left Ventricle
79%
Lung
31%
Lymphocyte
22%
Malignant Neoplasm
86%
Milrinone
19%
Mitral Insufficiency
32%
Multivariate Analysis
17%
Myocarditis
81%
Neutrophil
25%
Odds Ratio
27%
Pembrolizumab
15%
Percutaneous Aortic Valve Replacement
19%
Prevalence
50%
Primary Percutaneous Coronary Intervention
19%
Right Ventricle
30%
Right Ventricular Function
16%
Sex Differences
20%
ST Segment Elevation Myocardial Infarction
35%
Stress Echocardiography
28%
Stroke Volume
42%
Systolic Dysfunction
31%
Thymus
19%
Troponin
31%
Keyphrases
Active Cancer
24%
Acute Decompensated Heart Failure
35%
All-cause Mortality
60%
Anthracycline Therapy
32%
Anthracyclines
33%
Breast Cancer
22%
Cancer Therapy
27%
Cancer Therapy-related Cardiac Dysfunction (CTRCD)
49%
Cardio-oncology
43%
Cardiopulmonary Exercise Test
22%
Cardiotoxicity
43%
Cardiovascular Events
20%
Clinical Outcomes
26%
Combined Stress
25%
Consecutive Patients
30%
Coronary Angiography
21%
COVID-19
57%
Diastolic Dysfunction
25%
Diastolic Function
31%
Echocardiographic
57%
Echocardiographic Parameters
19%
Echocardiography
51%
Ejection Fraction
25%
Global Longitudinal Strain
28%
Heart Failure
43%
Heart Failure Hospitalization
21%
Heart Failure Patients
31%
Heart Failure with Preserved Ejection Fraction (HFpEF)
24%
High-sensitivity Troponin
20%
Immune Checkpoint Inhibitor Myocarditis
48%
Immune Checkpoint Inhibitors
86%
Interatrial Shunt
22%
Left Ventricle
46%
Left Ventricular Ejection Fraction
43%
Left Ventricular Strain
34%
Longitudinal Strain
22%
Mitral Regurgitation
25%
Myocarditis
40%
Neutrophil-to-lymphocyte Ratio
22%
Odds Ratio
21%
Predictive Value
32%
Preserved Ejection Fraction
25%
Prognostic Value
41%
Right Ventricle
24%
Right Ventricular
19%
Right Ventricular Strain
20%
Sodium-glucose Cotransporter 2 Inhibitors (SGLT2i)
22%
ST-elevation Myocardial Infarction (STEMI)
23%
Stress Echocardiography
28%
Stroke Volume
31%